Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000732957 | SCV000860959 | uncertain significance | not provided | 2018-04-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002535306 | SCV003517913 | uncertain significance | Zellweger spectrum disorders | 2022-07-31 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with PEX1-related conditions. This sequence change replaces arginine, which is basic and polar, with lysine, which is basic and polar, at codon 204 of the PEX1 protein (p.Arg204Lys). This variant is present in population databases (rs369126779, gnomAD 0.01%). ClinVar contains an entry for this variant (Variation ID: 596973). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt PEX1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Breakthrough Genomics, |
RCV000732957 | SCV005196033 | uncertain significance | not provided | criteria provided, single submitter | not provided |